Given that our understanding of how RB1 loss in vitro or in model organisms changes the LINC expression profile is limited, determining how RB1 homozygote mutation affects LINC levels in a complex and developmentally disorganized Retinoblastoma tumor represents a real challenge. The gene discussed is RB1; the disease is neoplasm.